The FDA granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old
News
Latest
When the best minds in health care come together on a national stage you can count on sparks flying, great discussions, new ideas emerging and the entire profession taking a step forward.
CMS shared a suite of new resources that can be used to improve state and federal monitoring and oversight of managed care in Medicaid and CHIP.
The HRSA announced that it will delay the withdrawal of HPSAs designated as "proposed for withdrawal" by one year.
HHS through the HRSA is making more than $142 million in Provider Relief Fund Phase 4 General Distribution payments to more than 150 providers across the country.
Mount Sinai Health System in New York is the 2022 Carolyn Boone Lewis Equity of Care Award winner.
CMS and the Office of the Assistant Secretary for Planning and Evaluation issued their report to Congress.
The Centers for Medicare & Medicaid Services today announced that it will delay indefinitely the payment penalty period of the Appropriate Use Criteria program for advanced imaging services.
CMS released its calendar year 2023 proposed rule for the physician fee schedule.
The FDA authorized state-licensed pharmacists to prescribe Paxlovid to patients as a treatment for those at high risk of severe COVID-19.
The seven-day average of daily hospitalization due to COVID-19 is up nearly 24% over the previous month, according to data from the Centers for Disease Control and Prevention and state health depar
The FBI issued a “white” joint cybersecurity advisory warning of ransomware threats against the U.S. health care and public sectors.
The AHA released a new fact sheet that hospital and health system leaders can use as they ask Congress to urge CMS to make two critical changes to the IPPS proposed rule.
Learn about the behavioral health achievements of Colorado’s rural Eagle Valley Behavioral Health.
HHS ordered an additional 2.5 million doses of an FDA-licensed vaccine for prevention of smallpox and monkeypox, for use in responding to current or future monkeypox outbreaks and as part of the nation’s smallpox preparedness.
The FDA last week revised its Evusheld fact sheet for health care providers, recommending repeat dosing every six months if patients need ongoing protection.
The Kaiser Family Foundation released an analysis of CMS data on claims denials and appeals by health plans on the marketplace.
The Centers for Medicare & Medicaid Services June 30 approved a state plan amendment allowing Washington state to extend postpartum coverage from 60 days to 12 months after pregnancy for Medicaid and Children’s Health Insurance Program enrollees under the American Rescue Plan Act.
The Centers for Disease Control and Prevention June 30 released guidance for all laboratories that perform diagnostics testing for monkeypox.
The Centers for Medicare & Medicaid Services June 29 updated its guidance regarding certain regulatory requirements for long-term care facilities participating in the Medicare and Medicaid programs